Latest Insider Transactions at Brooklyn Immuno Therapeutics, Inc. (BTX)
This section provides a real-time view of insider transactions for Brooklyn Immuno Therapeutics, Inc. (BTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Brooklyn ImmunoTherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Brooklyn ImmunoTherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 29
2024
|
Charles Cherington > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,819,546
+14.5%
|
$0
$0.5 P/Share
|
|
Oct 29
2024
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
13,252,112
+25.3%
|
-
|
|
Jun 21
2024
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-13.19%
|
$180
$1.94 P/Share
|
|
Jun 21
2024
|
Sandra M Gurrola Sr. VP of Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
437
+24.25%
|
-
|
|
Jun 21
2023
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-16.17%
|
$358
$2.48 P/Share
|
|
Jun 21
2023
|
Sandra M Gurrola Sr. VP of Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
438
+28.35%
|
-
|
|
Dec 02
2022
|
Charles Cherington > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
261,756
+31.99%
|
$785,268
$3.28 P/Share
|
|
Dec 02
2022
|
Nicholas Jason Singer |
BUY
Open market or private purchase
|
Indirect |
283,286
+40.57%
|
$849,858
$3.28 P/Share
|
|
Dec 02
2022
|
John D Halpern > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
335,920
+42.69%
|
$1,007,760
$3.28 P/Share
|
|
Sep 20
2022
|
Roger Sidhu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,163
+50.0%
|
-
|
|
Jun 28
2022
|
Kevin D Amour Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,077
-34.58%
|
$0
$0.55 P/Share
|
|
Jun 28
2022
|
Kevin D Amour Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,573
+50.0%
|
-
|
|
Jun 21
2022
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
3,586
-21.15%
|
$0
$0.48 P/Share
|
|
Jun 21
2022
|
Sandra M Gurrola Sr. VP of Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+34.04%
|
-
|
|
Jul 14
2021
|
George P Denny Iii > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1
+25.0%
|
$11
$11.99 P/Share
|
|
Jul 09
2021
|
George P Denny Iii > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1
+33.33%
|
$14
$14.11 P/Share
|
|
Jul 08
2021
|
George P Denny Iii > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1
+50.0%
|
$14
$14.35 P/Share
|
|
Jul 06
2021
|
George P Denny Iii > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
75,000
-1.55%
|
$1,200,000
$16.06 P/Share
|
|
Jun 17
2021
|
Charles Cherington > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-1.64%
|
$3,200,000
$16.02 P/Share
|
|
Jun 16
2021
|
Charles Cherington > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-3.18%
|
$3,000,000
$15.73 P/Share
|
|
Jun 01
2021
|
Charles Cherington > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
92
+0.0%
|
-
|
|
Mar 24
2021
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
6,094
-21.99%
|
$12,188
$2.67 P/Share
|
|
Mar 24
2021
|
Allen Wolff Former Director and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,944
-7.18%
|
$19,888
$2.67 P/Share
|
|
Mar 19
2021
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
116
-0.42%
|
$348
$3.53 P/Share
|
|
Mar 19
2021
|
Allen Wolff Former Director and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-0.15%
|
$621
$3.53 P/Share
|
|
Feb 19
2021
|
Allen Wolff Former Director and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-0.15%
|
$828
$4.81 P/Share
|
|
Feb 19
2021
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.41%
|
$460
$4.81 P/Share
|
|
Jan 19
2021
|
Allen Wolff Former Director and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,987
-2.11%
|
$5,974
$2.55 P/Share
|
|
Jan 19
2021
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
1,400
-4.77%
|
$2,800
$2.55 P/Share
|
|
Dec 19
2020
|
Allen Wolff Former Director and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-0.12%
|
$340
$2.17 P/Share
|
|
Dec 19
2020
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-0.34%
|
$200
$2.17 P/Share
|
|
Nov 20
2020
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-0.33%
|
$98
$1.88 P/Share
|
|
Nov 20
2020
|
Allen Wolff Former Director and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-0.12%
|
$170
$1.88 P/Share
|
|
Oct 21
2020
|
Allen Wolff Former Director and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,453
-1.7%
|
$4,906
$2.05 P/Share
|
|
Oct 21
2020
|
Sandra M Gurrola Sr. VP of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
1,178
-3.83%
|
$2,356
$2.05 P/Share
|
|
Mar 14
2018
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,000
-10.02%
|
$168,000
$6.24 P/Share
|
|
Mar 13
2018
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,426
-0.78%
|
$26,556
$6.92 P/Share
|
|
Mar 12
2018
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,253
-0.49%
|
$25,518
$6.84 P/Share
|
|
Nov 30
2017
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,000
-1.71%
|
$25,000
$5.05 P/Share
|
|
Nov 29
2017
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,061
-1.18%
|
$35,305
$5.12 P/Share
|
|
Nov 28
2017
|
Awm Investment Company, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,774
-1.74%
|
$53,870
$5.11 P/Share
|